APO RESEARCH · REPORT
Omega-3
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Product & engineering
Understand the product.
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Selected research
Industry Research
Omega-3 Industry Research Report 2026
Market perspective
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Global Omega-3 main players are DSM, BASF, Marine Ingredients, OLVEA Fish Oils, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 35%.
Report Scope
Read the full market overview
This report quantifies the global Omega-3 market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Omega-3.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omega-3 Market by Company
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma (Marine Ingredients)
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Orkla Health
LYSI
OLVEA Fish Oils
Hofseth BioCare
Nippon Suisan Kaisha
Bioprocess Algae
Shandong Yuwang Pharmaceutical
Maruha Nichiro Foods
Solutex
Omega-3 Segment by Type
Marine Omega-3
Algae Omega-3
Omega-3 Segment by Application
Dietary Supplements
Fortified Food and Beverage
Infant Formula
Pharmaceuticals
Pet Foods
Others
Omega-3 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega-3.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Omega-3 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Omega-3 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Omega-3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Omega-3
- Algae Omega-3
Applications
- Dietary Supplements
- Fortified Food and Beverage
- Infant Formula
- Pharmaceuticals
- Pet Foods
- Others
Companies covered
- DSM
- BASF
- EPAX
- Golden Omega
- TASA
- Omega Protein
- Croda
- KD Pharma (Marine Ingredients)
- GC Rieber
- Polaris
- Auqi
- Kinomega
- Skuny
- Xinzhou
- Anti-Cancer
- Sinomega
- Orkla Health
- LYSI
- OLVEA Fish Oils
- Hofseth BioCare
- Nippon Suisan Kaisha
- Bioprocess Algae
- Shandong Yuwang Pharmaceutical
- Maruha Nichiro Foods
- Solutex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Omega-3 by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Marine Omega-3
- 2.2.3 Algae Omega-3
- 2.3 Omega-3 by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dietary Supplements
- 2.3.3 Fortified Food and Beverage
- 2.3.4 Infant Formula
- 2.3.5 Pharmaceuticals
- 2.3.6 Pet Foods
- 2.3.7 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Omega-3 Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Omega-3 Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Omega-3 Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Omega-3 Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Omega-3 Production by Manufacturers (2021-2026)
- 3.2 Global Omega-3 Production Value by Manufacturers (2021-2026)
- 3.3 Global Omega-3 Average Price by Manufacturers (2021-2026)
- 3.4 Global Omega-3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Omega-3 Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Omega-3 Manufacturers, Product Type & Application
- 3.7 Global Omega-3 Manufacturers Established Date
- 3.8 Global Omega-3 Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DSM
- 4.1.1 DSM Omega-3 Company Information
- 4.1.2 DSM Omega-3 Business Overview
- 4.1.3 DSM Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 DSM Product Portfolio
- 4.1.5 DSM Recent Developments
- 4.2 BASF
- 4.2.1 BASF Omega-3 Company Information
- 4.2.2 BASF Omega-3 Business Overview
- 4.2.3 BASF Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 BASF Product Portfolio
- 4.2.5 BASF Recent Developments
- 4.3 EPAX
- 4.3.1 EPAX Omega-3 Company Information
- 4.3.2 EPAX Omega-3 Business Overview
- 4.3.3 EPAX Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 EPAX Product Portfolio
- 4.3.5 EPAX Recent Developments
- 4.4 Golden Omega
- 4.4.1 Golden Omega Omega-3 Company Information
- 4.4.2 Golden Omega Omega-3 Business Overview
- 4.4.3 Golden Omega Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Golden Omega Product Portfolio
- 4.4.5 Golden Omega Recent Developments
- 4.5 TASA
- 4.5.1 TASA Omega-3 Company Information
- 4.5.2 TASA Omega-3 Business Overview
- 4.5.3 TASA Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 TASA Product Portfolio
- 4.5.5 TASA Recent Developments
- 4.6 Omega Protein
- 4.6.1 Omega Protein Omega-3 Company Information
- 4.6.2 Omega Protein Omega-3 Business Overview
- 4.6.3 Omega Protein Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Omega Protein Product Portfolio
- 4.6.5 Omega Protein Recent Developments
- 4.7 Croda
- 4.7.1 Croda Omega-3 Company Information
- 4.7.2 Croda Omega-3 Business Overview
- 4.7.3 Croda Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Croda Product Portfolio
- 4.7.5 Croda Recent Developments
- 4.8 KD Pharma (Marine Ingredients)
- 4.8.1 KD Pharma (Marine Ingredients) Omega-3 Company Information
- 4.8.2 KD Pharma (Marine Ingredients) Omega-3 Business Overview
- 4.8.3 KD Pharma (Marine Ingredients) Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 KD Pharma (Marine Ingredients) Product Portfolio
- 4.8.5 KD Pharma (Marine Ingredients) Recent Developments
- 4.9 GC Rieber
- 4.9.1 GC Rieber Omega-3 Company Information
- 4.9.2 GC Rieber Omega-3 Business Overview
- 4.9.3 GC Rieber Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 GC Rieber Product Portfolio
- 4.9.5 GC Rieber Recent Developments
- 4.10 Polaris
- 4.10.1 Polaris Omega-3 Company Information
- 4.10.2 Polaris Omega-3 Business Overview
- 4.10.3 Polaris Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Polaris Product Portfolio
- 4.10.5 Polaris Recent Developments
- 4.11 Auqi
- 4.11.1 Auqi Omega-3 Company Information
- 4.11.2 Auqi Omega-3 Business Overview
- 4.11.3 Auqi Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Auqi Product Portfolio
- 4.11.5 Auqi Recent Developments
- 4.12 Kinomega
- 4.12.1 Kinomega Omega-3 Company Information
- 4.12.2 Kinomega Omega-3 Business Overview
- 4.12.3 Kinomega Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Kinomega Product Portfolio
- 4.12.5 Kinomega Recent Developments
- 4.13 Skuny
- 4.13.1 Skuny Omega-3 Company Information
- 4.13.2 Skuny Omega-3 Business Overview
- 4.13.3 Skuny Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Skuny Product Portfolio
- 4.13.5 Skuny Recent Developments
- 4.14 Xinzhou
- 4.14.1 Xinzhou Omega-3 Company Information
- 4.14.2 Xinzhou Omega-3 Business Overview
- 4.14.3 Xinzhou Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Xinzhou Product Portfolio
- 4.14.5 Xinzhou Recent Developments
- 4.15 Anti-Cancer
- 4.15.1 Anti-Cancer Omega-3 Company Information
- 4.15.2 Anti-Cancer Omega-3 Business Overview
- 4.15.3 Anti-Cancer Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Anti-Cancer Product Portfolio
- 4.15.5 Anti-Cancer Recent Developments
- 4.16 Sinomega
- 4.16.1 Sinomega Omega-3 Company Information
- 4.16.2 Sinomega Omega-3 Business Overview
- 4.16.3 Sinomega Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Sinomega Product Portfolio
- 4.16.5 Sinomega Recent Developments
- 4.17 Orkla Health
- 4.17.1 Orkla Health Omega-3 Company Information
- 4.17.2 Orkla Health Omega-3 Business Overview
- 4.17.3 Orkla Health Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Orkla Health Product Portfolio
- 4.17.5 Orkla Health Recent Developments
- 4.18 LYSI
- 4.18.1 LYSI Omega-3 Company Information
- 4.18.2 LYSI Omega-3 Business Overview
- 4.18.3 LYSI Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.18.4 LYSI Product Portfolio
- 4.18.5 LYSI Recent Developments
- 4.19 OLVEA Fish Oils
- 4.19.1 OLVEA Fish Oils Omega-3 Company Information
- 4.19.2 OLVEA Fish Oils Omega-3 Business Overview
- 4.19.3 OLVEA Fish Oils Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.19.4 OLVEA Fish Oils Product Portfolio
- 4.19.5 OLVEA Fish Oils Recent Developments
- 4.20 Hofseth BioCare
- 4.20.1 Hofseth BioCare Omega-3 Company Information
- 4.20.2 Hofseth BioCare Omega-3 Business Overview
- 4.20.3 Hofseth BioCare Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.20.4 Hofseth BioCare Product Portfolio
- 4.20.5 Hofseth BioCare Recent Developments
- 4.21 Nippon Suisan Kaisha
- 4.21.1 Nippon Suisan Kaisha Omega-3 Company Information
- 4.21.2 Nippon Suisan Kaisha Omega-3 Business Overview
- 4.21.3 Nippon Suisan Kaisha Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.21.4 Nippon Suisan Kaisha Product Portfolio
- 4.21.5 Nippon Suisan Kaisha Recent Developments
- 4.22 Bioprocess Algae
- 4.22.1 Bioprocess Algae Omega-3 Company Information
- 4.22.2 Bioprocess Algae Omega-3 Business Overview
- 4.22.3 Bioprocess Algae Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.22.4 Bioprocess Algae Product Portfolio
- 4.22.5 Bioprocess Algae Recent Developments
- 4.23 Shandong Yuwang Pharmaceutical
- 4.23.1 Shandong Yuwang Pharmaceutical Omega-3 Company Information
- 4.23.2 Shandong Yuwang Pharmaceutical Omega-3 Business Overview
- 4.23.3 Shandong Yuwang Pharmaceutical Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.23.4 Shandong Yuwang Pharmaceutical Product Portfolio
- 4.23.5 Shandong Yuwang Pharmaceutical Recent Developments
- 4.24 Maruha Nichiro Foods
- 4.24.1 Maruha Nichiro Foods Omega-3 Company Information
- 4.24.2 Maruha Nichiro Foods Omega-3 Business Overview
- 4.24.3 Maruha Nichiro Foods Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.24.4 Maruha Nichiro Foods Product Portfolio
- 4.24.5 Maruha Nichiro Foods Recent Developments
- 4.25 Solutex
- 4.25.1 Solutex Omega-3 Company Information
- 4.25.2 Solutex Omega-3 Business Overview
- 4.25.3 Solutex Omega-3 Production Capacity, Value and Gross Margin (2021-2026)
- 4.25.4 Solutex Product Portfolio
- 4.25.5 Solutex Recent Developments
5 Global Omega-3 Production by Region
- 5.1 Global Omega-3 Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Omega-3 Production by Region: 2021-2032
- 5.2.1 Global Omega-3 Production by Region: 2021-2026
- 5.2.2 Global Omega-3 Production Forecast by Region (2027-2032)
- 5.3 Global Omega-3 Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Omega-3 Production Value by Region: 2021-2032
- 5.4.1 Global Omega-3 Production Value by Region: 2021-2026
- 5.4.2 Global Omega-3 Production Value Forecast by Region (2027-2032)
- 5.5 Global Omega-3 Market Price Analysis by Region (2021-2026)
- 5.6 Global Omega-3 Production and Value, YOY Growth
- 5.6.1 North America Omega-3 Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Omega-3 Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Omega-3 Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Omega-3 Production Value Estimates and Forecasts (2021-2032)
6 Global Omega-3 Consumption by Region
- 6.1 Global Omega-3 Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Omega-3 Consumption by Region (2021-2032)
- 6.2.1 Global Omega-3 Consumption by Region: 2021-2026
- 6.2.2 Global Omega-3 Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Omega-3 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Omega-3 Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Omega-3 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Omega-3 Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Omega-3 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Omega-3 Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Omega-3 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Omega-3 Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Omega-3 Production by Type (2021-2032)
- 7.1.1 Global Omega-3 Production by Type (2021-2032) & (MT)
- 7.1.2 Global Omega-3 Production Market Share by Type (2021-2032)
- 7.2 Global Omega-3 Production Value by Type (2021-2032)
- 7.2.1 Global Omega-3 Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Omega-3 Production Value Market Share by Type (2021-2032)
- 7.3 Global Omega-3 Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Omega-3 Production by Application (2021-2032)
- 8.1.1 Global Omega-3 Production by Application (2021-2032) & (MT)
- 8.1.2 Global Omega-3 Production Market Share by Application (2021-2032)
- 8.2 Global Omega-3 Production Value by Application (2021-2032)
- 8.2.1 Global Omega-3 Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Omega-3 Production Value Market Share by Application (2021-2032)
- 8.3 Global Omega-3 Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Omega-3 Value Chain Analysis
- 9.1.1 Omega-3 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Omega-3 Production Mode & Process
- 9.2 Omega-3 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Omega-3 Distributors
- 9.2.3 Omega-3 Customers
10 Global Omega-3 Analyzing Market Dynamics
- 10.1 Omega-3 Industry Trends
- 10.2 Omega-3 Industry Drivers
- 10.3 Omega-3 Industry Opportunities and Challenges
- 10.4 Omega-3 Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst